Early research (Phase 1)Study completedNCT00813618What this trial is testingStudy of MEDI 507 in the Treatment of Pediatric PatientsWho this might be right forGraft Versus Host Disease MedImmune LLC 10
Testing effectiveness (Phase 2)UnknownNCT06133192What this trial is testingSteroids Versus ECP and Steroids as First-line Treatment of Grade II Acute GVHDWho this might be right forGraft Vs Host Disease Central Hospital, Nancy, France 42
Large-scale testing (Phase 3)Ended earlyNCT00089141What this trial is testingMycophenolate Mofetil (MMF) for Treatment of Chronic Graft-versus-host Disease (GVHD)Who this might be right forCancer Martin, Paul 151
Not applicableStudy completedNCT00053157What this trial is testingSargramostim in Reducing Graft-Versus-Host Disease in Patients Who Are Undergoing Donor Stem Cell Transplantation for Hematologic Cancer or Aplastic AnemiaWho this might be right forChronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+3 more Roswell Park Cancer Institute 10
Early research (Phase 1)Study completedNCT00806728What this trial is testingStudy of MEDI-507 in With Steroid-Resistant Acute Graft-Versus-Host DiseaseWho this might be right forCancerGraft-Versus-Host Disease MedImmune LLC 17
Testing effectiveness (Phase 2)UnknownNCT01596075What this trial is testingSafety and Efficacy of Cannabidiol for Grade I/II Acute Graft Versus Host Disease (GVHD) After Allogeneic Stem Cell TransplantationWho this might be right forGraft Versus Host Disease Rabin Medical Center 40
Large-scale testing (Phase 3)Study completedNCT02336230What this trial is testingA Prospective Study of Remestemcel-L, Ex-vivo Cultured Adult Human Mesenchymal Stromal Cells, for the Treatment of Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute Graft-Versus-Host Disease (aGVHD)Who this might be right forGrade B aGVHDGrade C aGVHDGrade D aGVHD Mesoblast, Inc. 55
Not applicableEnded earlyNCT00255684What this trial is testingFludarabine, Cyclophosphamide, and Total-Body Irradiation Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients Who Are Undergoing a Donor Umbilical Cord Blood Transplant for Hematologic CancerWho this might be right forChronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+4 more University of Rochester 16
Large-scale testing (Phase 3)Study completedNCT00755040What this trial is testingCyclosporine Eye Drops in Preventing Graft-Versus-Host Disease of the Eye in Patients Who Have Undergone Donor Stem Cell Transplant for Hematologic Cancer or Bone Marrow Failure DisorderWho this might be right forChronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+4 more Vanderbilt-Ingram Cancer Center 164
Large-scale testing (Phase 3)Study completedNCT00726375What this trial is testingThe Use of Etanercept Enbrel as Sole Treatment for Grade I Acute Graft Versus Host DiseaseWho this might be right forAcute Graft Versus Host Disease University of Michigan Rogel Cancer Center 34
Testing effectiveness (Phase 2)Study completedNCT00611351What this trial is testingBusulfan, Cyclophosphamide, & Antithymocyte Globulin Followed by Stem Cell Transplant in Treating Hematologic CancerWho this might be right forGraft Versus Host DiseaseLeukemiaLymphoma+4 more University of Nebraska 5
Testing effectiveness (Phase 2)Study completedNCT03847844What this trial is testingUCMSCs as Front-line Approach of Treatment for Patients With aGVHDWho this might be right forAcute-graft-versus-host Disease Cytopeutics Sdn. Bhd. 26
Testing effectiveness (Phase 2)Study completedNCT01427881What this trial is testingCyclophosphamide for Prevention of Graft-Versus-Host Disease After Allogeneic Peripheral Blood Stem Cell Transplantation in Patients With Hematological MalignanciesWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Megakaryoblastic Leukemia (M7)+65 more Fred Hutchinson Cancer Center 43
Testing effectiveness (Phase 2)Study completedNCT03491215What this trial is testingStudy of Pharmacokinetics, Activity and Safety of Ruxolitinib in Pediatric Patients With Grade II-IV Acute Graft vs. Host DiseaseWho this might be right forAcute Graft Versus Host Disease Novartis Pharmaceuticals 45
Testing effectiveness (Phase 2)Study completedNCT00003335What this trial is testingUmbilical Cord Blood Transplantation in Treating Patients With High-Risk Hematologic CancerWho this might be right forGraft Versus Host DiseaseLeukemiaLymphoma+2 more Case Comprehensive Cancer Center 44
Testing effectiveness (Phase 2)UnknownNCT04958538What this trial is testingMTX and Steroid for III-IV aGVHD TreatmentWho this might be right forAcute Graft Versus Host Disease Peking University People's Hospital 30
Large-scale testing (Phase 3)Study completedNCT00265837What this trial is testingLaboratory-Treated Donor Bone Marrow in Treating Patients Who Are Undergoing a Donor Bone Marrow Transplant for Hematologic CancerWho this might be right forGraft Versus Host DiseaseLeukemiaLymphoma+3 more Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 72
Testing effectiveness (Phase 2)Study completedNCT00089037What this trial is testingSirolimus, Tacrolimus, and Methotrexate in Preventing Acute Graft-Versus-Host Disease in Patients With Hematologic Cancer Who Are Undergoing Donor Stem Cell TransplantationWho this might be right forChronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+4 more Fred Hutchinson Cancer Center
Large-scale testing (Phase 3)Study completedNCT02652130What this trial is testingSafety Follow-up of Treatment With Remestemcel-L in Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute GVHDWho this might be right forGrade B Acute Graft Versus Host DiseaseGrade C Acute Graft Versus Host DiseaseGrade D Acute Graft Versus Host Disease Mesoblast, Inc. 32
Testing effectiveness (Phase 2)UnknownNCT04448587What this trial is testingSitagliptin for the Treatment of Grade 3-4 and Refractory Acute Graft-versus-host DiseaseWho this might be right forGraft Vs Host Disease Rabin Medical Center 10